BioCentury | Feb 11, 2013
Company News

Natur Produkt International, Valeant Pharmaceuticals deal

...$163 million, plus adjustments for net debt and working capital (see BioCentury, April 9, 2012). Natur Produkt International JSC...
BioCentury | Apr 9, 2012
Company News

Natur Produkt International JSC, Valeant Pharmaceuticals deal

...remedies, including AntiGrippin. The acquisition is expected to be accretive immediately. Terms were not disclosed. Natur Produkt International JSC...
Items per page:
1 - 2 of 2
BioCentury | Feb 11, 2013
Company News

Natur Produkt International, Valeant Pharmaceuticals deal

...$163 million, plus adjustments for net debt and working capital (see BioCentury, April 9, 2012). Natur Produkt International JSC...
BioCentury | Apr 9, 2012
Company News

Natur Produkt International JSC, Valeant Pharmaceuticals deal

...remedies, including AntiGrippin. The acquisition is expected to be accretive immediately. Terms were not disclosed. Natur Produkt International JSC...
Items per page:
1 - 2 of 2